• Shelia Savell, Alejandra G Mora, Crystal A Perez, Vikhyat S Bebarta, and Maj Joseph K Maddry.
• United States Air Force En Route Care Research Center/59th MDW/ST-United States Army Institute of Surgical Research, JBSA Ft. Sam Houston, Texas.
• Am J Disaster Med. 2016 Jan 1; 11 (4): 225-231.

ObjectiveTo describe and compare vascular access practices used by en route care providers during medical evacuation (MEDEVAC).DesignThis was a retrospective cohort study. Medical records of US military personnel injured in combat and transported by MEDEVAC teams were queried.PatientsThe subjects were transported by military en route care providers, in the combat theater during Operation Enduring Freedom (OEF) between January 2011 and March 2014. The authors reviewed 1,267 MEDEVAC records of US casualties and included 832 subjects that had vascular access attempts.Main Outcome MeasuresThe outcome measures for this study were vascular access success rates, including intravenous (IV) and intraosseous (IO) attempts. Subjects were grouped by type of vascular access: None, peripheral intravenous (PIV), IO, and PIV + IO (combination of PIV and IO) and by vascular access (PIV or IO) success (No versus Yes). Survival rate, in-flight events, ventilator, intensive care and in hospital days, and 30-day outcomes were compared among groups.Statistical AnalysisThe authors used chisquare or Fisher's exact tests to evaluate categorical variables. Analysis of variance (ANOVA) or Kruskal-Wallis tests were used for continuous variables.ResultsVascular access was attempted in 832 (66 percent) of the 1,267 subjects transported by MEDEVAC during this study period. The majority (n = 758) of the access attempts were PIV of which 93 percent (706/758) were successful. In 74 subjects, IO was the only access attempted with an 85 percent (n = 63) success rate. The overall success rate with IO placement was 88 percent.ConclusionsIntraosseous access has been used successfully in the combat setting and accounts for approximately 12 percent of vascular access in the MEDEVAC population the authors studied.

23 keywords...

hide…